Zoetis Inc. (NYSE: ZTS) today announced the commercial launch of Portela ® (relfovetmab) in Canada and the European Union (EU) member states. Portela is the first long-acting anti-nerve growth factor ...
When Sanofi won FDA approval in July 2026 for the first anticancer treatment administered with an on-body injector (OBI), the Enable Injections enFuse platform made it possible. The enFuse OBI secured ...
According to Carney, who was present for his birth, Tornado was the biggest puppy of the litter and has lived up to his name ...
(NYSE: ZTS) today announced that it has recently launched Lenivia ® (izenivetmab injection) in Canada and the Europea ...
The FDA has approved a subcutaneous version of isatuximab (Sarclisa Escena, Sanofi-Aventis) for several multiple myeloma (MM) indications. Sarclisa Escena can be administered with the hands-free ...
Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector Sarclisa Escena administered via the CirCLIQ ® on-body injector (OBI) offers a ...
Hosted on MSN
SubQ: The LLM breakthrough using 1000x less compute
This video breaks down SubQ, a new LLM architecture claiming massive efficiency gains through subquadratic sparse attention. It explains how SubQ could handle up to 12 million tokens, reduce compute ...
aDivision of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America bDivision of Gastroenterology, Hepatology and Endoscopy, Brigham ...
aDepartment of Medicine ‘B’, Sheba Medical Center, Ramat Gan, Israel Over the past decade, subcutaneous formulations of anticancer drugs—originally administered intravenously—have been increasingly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results